Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats

European Journal of Pharmacology

Volumn 390, Issue 3, 2000, Pages 303-311

  Bespalov, Anton Y ^a   Dravolina, Olga A ^a   Zvartau, Edwin E ^a   Beardsley, Patrick M ^b   Balster, Robert L ^b  

^a Inst P   (Russian Federation)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

ACEA 1021; Cocaine; Conditioning; D CPPene (SDZ EAA 494); Dizocilpine (MK 801); Eliprodil; Memantine; Motor activity; Rat

Indexed keywords

4 (3 PHOSPHONOALLYL) 2 PIPERAZINECARBOXYLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; COCAINE; DIZOCILPINE; ELIPRODIL; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMANTINE; MOTOR ACTIVITY; PIPERAZINES; PIPERIDINES; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0034598960     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00927-9     Document Type: Article

References (53)

1. Ahmed S.H., Oberling P., Di Scala G., Sandner G. Amphetamine-induced conditioned activity does not result from a failure of rats to habituate to novelty. Psychopharmacology. 123:1996;325-332.
2. Balster R.L., Mansbach R.S., Shelton K.L., Nicholson K.L., Grech D.M., Wiley J.L., Li H., Weber E. Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav. Pharmacol. 6:1995;577-589.
3. Balster R.L., Nicholson K.L., Sanger D.J. Evaluation of the reinforcing effects of eliprodil in rhesus monkeys and its discriminative stimulus effects in rats. Drug Alcohol Depend. 35:1994;211-216.
4. Balster R.L., Willetts J. Phencyclidine: a drug of abuse and a tool for neuroscience research. Schuster C.R., Kuhar M.J. Pharmacological Aspects of Drug Dependence: Towards an Integrated Neurobehavioral Approach. Handbook of Experimental Pharmacology. Vol. 118:1996;233-262 Springer, Berlin.
5. Barat S.A., Abdel-Rahman M.S. Decreased cocaine-and lidocaine-induced seizure response by dextromethorphan and DNQX in rat. Brain Res. 756:1997;179-183.
6. Beardsley P.M., Hayes B.A., Balster R.L. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys. J. Pharmacol. Exp. Ther. 252:1990;953-959.
7. Bespalov A.Y. The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned place aversion is attenuated by the NMDA receptor antagonist (±)-CPP. Drug Alcohol Depend. 41:1996;85-88.
8. Bespalov A.Y., Dumpis M.A., Piotrovsky L.B., Zvartau E.E. Excitatory amino acid receptors antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239.
9. Bespalov A.Y., Tokarz M.E., Bowen S.E., Beardsley P.M., Balster R.L. Effects of test conditions on the outcome of place conditioning in mice. Psychopharmacology. 141:1999;118-122.
10. Bespalov A.Y., Zvartau E.E. Intra-accumbens administration of NMDA receptor antagonist (±)-CPP prevents locomotor activation conditioned by morphine and amphetamine. Pharmacol. Biochem. Behav. 55:1996;203-207.
11. Bespalov A.Y., Zvartau E.E. NMDA receptor antagonists prevent the activation of intracranial self-stimulation induced by conditioned visual stimulus in rats. Eur. J. Pharmacol. 324:1997;128-134.
12. Boast C.A., Pastor G., Gerhardt S.C., Hall N.R., Liebman J.M. Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 247:1988;556-561.
13. Bozarth M.A. Conditioned place preference: a parametric analysis using systemic heroin injections. Bozarth M.A. Methods of Assessing the Reinforcing Properties of Abused Drugs. 1987;241-273 Springer, New York.
14. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28:1989;653-661.
15. Carlezon W.A. Jr., Wise R.A. Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology. 128:1996;413-420.
16. Carter C., Avenet P., Benavides J., Besnard F., Biton B., Cudennec A., Duverger D., Frost J., Giroux C., Graham D., Langer S.Z., Nowick J.P., Oblin A., Perrault G., Pigasse S., Rosen P., Sanger D., Schoemaker H., Thenot J.P., Scatton B. Ifenprodil and eliprodil: neuroprotective NMDA receptor antagonists and calcium channel blockers. Herrling P.L. Excitatory Amino Acids - Clinical Results with Antagonists. 1997;57-80 Academic Press, San Diego.
17. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 1995;242-250.
18. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats. Brain Res. 731:1996;31-38.
19. Chang J.-Y., Sawyer S.F., Lee R.-S., Woodward D.J. Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J. Neurosci. 14:1994;1224-1244.
20. Corbett D. Possible abuse potential of the NMDA antagonist MK-801. Behav. Brain Res. 34:1989;239-246.
21. Damianopoulos E.N., Carey R.J. Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68:1995;219-228.
22. Danysz W., Essmann U., Bresink I., Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48:1994;111-118.
23. Danysz W., Parsons C.G., Kornhuber J., Schmidt W.J., Quack G. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci. Biobehav. Rev. 21:1997;455-468.
24. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., Vanderschuren L.J. MK-801 reinstates drug-seeking behaviour in cocaine-trained rats. NeuroReport. 9:1998;637-640.
25. Druhan J.P., Wilent W.B. Effects of the competitive N-methyl-D-aspartate receptor antagonist, CPP, on the development and expression of conditioned hyperactivity and sensitization induced by cocaine. Behav. Brain Res. 102:1999;195-210.
26. Fuller T.A., Russchen F.T., Price J.L.P. Sources of presumptive glutamatergic/aspartatergic afferents to the rat ventral striatopallidal region. J. Comp. Neurol. 258:1987;317-338.
27. Hageman G.R., Simor T. Attenuation of the cardiac effects of cocaine by dizocilpine. Am. J. Physiol. 264:1993;H1890-H1895.
28. Herrling P.L., Emre M., Watkins J.C. D-CPPene (SDZ EAA 494) - a competitive NMDA antagonist: pharmacology and results in humans. Herrling P.L. Excitatory Amino Acids - Clinical Results with Antagonists. 1997;7-22 Academic Press, San Diego.
29. Kantak K.M., Edwards M.A., O'Connor T.P. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists. Pharmacol. Biochem. Behav. 59:1998;159-169.
30. Kelley A.E., Domesick V.B. The distribution of projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde and retrograde horseradish peroxidase study. Neuroscience. 7:1982;2321-2334.
31. Kelley A.E., Domesick V.B., Nauta W.J.H. The amygdalostriatal projections in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-626.
32. Kim H.S., Park W.K., Jang C.G., Oh S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40:1996;201-207.
33. Mackintosh N.J. The Psychology of Animal Learning. 1974;Academic Press, London.
34. Matsumoto R.R., Brackett R.L., Kanthasamy A.G. Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity. Eur. J. Pharmacol. 338:1997;233-242.
35. Nicholson K.L., Jones H.E., Balster R.L. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Behav. Pharmacol. 9:1998;231-243.
36. Pap A., Bradberry C.W. Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther. 274:1995;127-133.
37. Parsons C.G., Quack G., Bresink I., Baran L., Przegalinski E., Kostowski W., Krzascik P., Hartmann S., Danysz W. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology. 34:1995;1239-1258.
38. Popik P., Danysz W. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J. Pharmacol. Exp. Ther. 280:1997;854-865.
39. Pulvirenti L., Balducci C., Koob G.F. Dextromethorphan reduces intravenous cocaine self-administration in the rat. Eur. J. Pharmacol. 321:1997;279-283.
40. Pulvirenti L., Maldonado-Lopez R., Koob G.F. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res. 594:1992;327-330.
41. Ranaldi R., Bauco P., Wise R.A. Synergistic effects of cocaine and dizocilpine (MK-801) on brain stimulation reward. Brain Res. 760:1997;231-237.
42. Ranaldi R., French E., Roberts D.C. Systemic pretreatment with MK-801 (dizocilpine) increases breaking points for self-administration of cocaine on a progressive-ratio schedule in rats. Psychopharmacology. 128:1996;83-88.
43. Robinson T.G., Beart P.M. Excitant amino acid projections from rat amygdala and thalamus to nucleus accumbens. Brain Res. Bull. 20:1988;467-471.
44. Stewart J., de Wit H., Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol. Rev. 91:1984;251-268.
45. Tirelli E., Terry P. Amphetamine-induced conditioned activity and sensitization: the role of habituation to the test context and the involvement of Pavlovian processes. Behav. Pharmacol. 9:1998;409-419.
46. Tzschentke T.M., Schmidt W.J. N-Methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193:1995;37-40.
47. Tzschentke T.M., Schmidt W.J. Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization. Behav. Brain Res. 84:1997;99-107.
48. Witkin J.M. Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci. 53:1993;PL405-PL410.
49. Witkin J.M., Acri J.B. Effects of ifenprodil on stimulatory, discriminative stimulus and convulsant effects of cocaine. Behav. Pharmacol. 6:1995;245-253.
50. Witkin J.M., Tortella F.C. Modulators of N-methyl-D-aspartate protect against diazepam-or phenobarbital-resistant cocaine convulsions. Life Sci. 48:1991;PL51-PL56.
51. Wolf M.E., Khansa M.R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
52. Wong E.H., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7104-7108.
53. Woodward R.M., Huettner J.E., Guastella J., Keana J.F., Weber E. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:1995;568-581.